Marie O’Farrell

Marie O’Farrell

Company: Sagimet

Job title: Vice President of Research & Development


TVB-2640, A Novel, First-in-Class, Fatty Acid Synthase (FASN) Inhibitor: Biomarker AND Metabolomic Correlations With Clinical MRI-PDFF Response 11:30 am

• FASN inhibition decreases liver fat and markers of inflammation and fibrosis in Phase 2 NASH • Correlation of non-invasive tests with liver fat clinical response • Investigation of serum metabolomic markers to predict liver fat clinical responseRead more

day: Day 2 Stream 3 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.